Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36526 - 36550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	ANXA1	301	downregulated	entinostat results in decreased expression of ANXA1 mRNA	9q21.13	A21037
Entinostat	Investigational	ANXA11	311	upregulated	entinostat results in increased expression of ANXA11 mRNA	10q22.3	A21035
Entinostat	Investigational	ANXA2	302	upregulated	entinostat results in increased expression of ANXA2 mRNA	15q22.2	A21037 A21035
Entinostat	Investigational	ANXA2P2	304	upregulated	entinostat results in increased expression of ANXA2P2 mRNA	9p13.3	A21037 A21035
Entinostat	Investigational	ANXA4	307	upregulated	entinostat results in increased expression of ANXA4 mRNA	2p13.3	A21037
Entinostat	Investigational	ANXA5	308	upregulated	entinostat results in increased expression of ANXA5 mRNA	4q27	A21035
Entinostat	Investigational	ANXA9	8416	upregulated	entinostat results in increased expression of ANXA9 mRNA	1q21.3	A21037
Entinostat	Investigational	AP1M2	10053	upregulated	entinostat results in increased expression of AP1M2 mRNA	19p13.2	A21037
Entinostat	Investigational	AP1S3	130340	upregulated	entinostat results in increased expression of AP1S3 mRNA	2q36.1	A21037 A21035
Entinostat	Investigational	AP3B2	8120	downregulated	entinostat results in decreased expression of AP3B2 mRNA	15q25.2	A21035
Entinostat	Investigational	AP3M1	26985	downregulated	entinostat results in decreased expression of AP3M1 mRNA	10q22.2	A21037
Entinostat	Investigational	APBA2	321	downregulated	entinostat results in decreased expression of APBA2 mRNA	15q13.1	A21037
Entinostat	Investigational	APBB2	323	upregulated	entinostat results in increased expression of APBB2 mRNA	4p14-p13	A21037
Entinostat	Investigational	APCDD1	147495	upregulated	entinostat results in increased expression of APCDD1 mRNA	18p11.22	A21035
Entinostat	Investigational	APELA	100506013	upregulated	entinostat results in increased expression of APELA mRNA	4q32.3	A21037
Entinostat	Investigational	APH1B	83464	upregulated	entinostat results in increased expression of APH1B mRNA	15q22.2	A21037
Entinostat	Investigational	APOBEC3B	9582	upregulated	entinostat results in increased expression of APOBEC3B mRNA	22q13.1	A21037 A21035
Entinostat	Investigational	APOE	348	upregulated	entinostat results in increased expression of APOE mRNA	19q13.32	A21037
Entinostat	Investigational	APOLD1	81575	downregulated	entinostat results in decreased expression of APOLD1 mRNA	12p13.1	A21037
Entinostat	Investigational	ARAP1	116985	upregulated	entinostat results in increased expression of ARAP1 mRNA	11q13.4	A21035
Entinostat	Investigational	ARHGAP24	83478	upregulated	entinostat results in increased expression of ARHGAP24 mRNA	4q21.23-q21.3	A21035
Entinostat	Investigational	ARHGAP26	23092	upregulated	entinostat results in increased expression of ARHGAP26 mRNA	5q31.3	A21035
Entinostat	Investigational	ARHGAP29	9411	downregulated	entinostat results in decreased expression of ARHGAP29 mRNA	1p22.1	A21037
Entinostat	Investigational	ARHGAP42	143872	upregulated	entinostat results in increased expression of ARHGAP42 mRNA	11q22.1	A21037
Entinostat	Investigational	ARHGAP5	394	downregulated	entinostat results in decreased expression of ARHGAP5 mRNA	14q12	A21037

Displaying entries 36526 - 36550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability